Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Patent
1997-02-12
2000-12-19
Clark, Deborah J.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
424 9321, 435325, A01N 6300, C12N 508
Patent
active
061624284
ABSTRACT:
Disclosed herein is the treatment of vision loss in a mammal by transplanting an effective amount of hNT-Neuron cells. The treatment can be accomplished by injecting the cells into the retinal area of the eye. Additionally, the cells can be injected into the visual cortex of the brain. Conditions to be treated are vision loss due to optic nerve damage, including glaucoma, optic nerve sheath meningioma and glioma, Graves' ophthalmopathy, benign or malignant orbital tumors, metastatic lesions, tumors arising from the adjacent paranasal sinuses or middle cranial fossa, giant pituitary adenomas, brain tumors or abscesses, cerebral trauma or hemorrhage, meningitis, arachnoidal adhesions, pseudotumor cerebri, cavernous sinus thrombosis, dural sinus thrombosis, encephalitis, space-occupying brain lesions, severe hypertensive disease or pulmonary emphysema.
REFERENCES:
patent: 5175103 (1992-12-01), Lee et al.
Rapp, L. M. Retinal Phototoxicity. Handbook of Neurotoxicity. Macel Dekker, Inc., pp. 963-1003, 1995.
Jackowski, A. Neural injury repair: hope for the future as barriers to effective CNS regeneration become clearer. British Journal of Neurosurgery, vol. 9, pp. 303-317, 1995.
Cerro et al., "Neural Retinal Transplantation into 12 RP Patients." Invest. Ophthal. Vis.Sci. 38(4):S261, 1997.
DiLoreto, Cerro and Cerro, "Cyclosporine treatment promotes survival of human fetal neural retina transplanted to the subretinal space of light-damaged fischer 344 rat." Experimental Neurology 140:37-42, 1996 (Jul.).
Honjo et al., "Estrogen as a growth factor to central nervous cells." Steroid Biochem. Molec. Biol. 41(3-8):633-635, 1992.
Olson et al., "Conditions for adrenergic hyperinnervation in hippocampus: histochemical evidence from intraocular double grafts." Exper. Brain Res. 39:277-88, 1980.
Little et al. "Transplantation of Human Fetal Retinal Pigment Epithelium Rescues Photoreceptor Cells From Degeneration in the Royal College of Surgeons Rat Retina." Invest Ophthalmol Vis Sci 37:204-11, 1996.
Aramant and Seiler, "Fiber and Synaptic Connections Between Embrionic Retinal Transplants and Host Retina." Experimental Neurology 133:244-55, 1995.
Castillo BV et al. "Efficacy of Nonfetal Human RPE for Photoreceptor Rescue: A Study in Dystrophic RCS Rats." Experimental Neurology 146(1):1-9, 1997.
Trojanowski et al. "Neurons from Human Teratocarcinoma Cell Line." ExperimNeurol 122:283-94, 1993.
Gutin et al., "Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources." J. Neurosurg 67:864-73, 1987.
Couldwelland Apuzzo. "Initial experience related to the use of the Cosman-Roberts-Wells stereotactic instrument." J. Neurosurg 72:145-48, 1990.
Clark Deborah J.
Layton Bioscience, Inc.
Luther Barbara J.
LandOfFree
hNT-neuron human neuronal cells to replace ganglion cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with hNT-neuron human neuronal cells to replace ganglion cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and hNT-neuron human neuronal cells to replace ganglion cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-268896